According to Abeona Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.33. In 2022 the company made an earnings per share (EPS) of -$9.67 an increase over its 2021 EPS that were of -$30.62.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.06 | -58.01% |
2022 | -$9.67 | -68.42% |
2021 | -$30.62 | -6.68% |
2020 | -$32.81 | -40.13% |
2019 | -$54.80 | 28.81% |
2018 | -$42.54 | 78.79% |
2017 | -$23.80 | 3.13% |
2016 | -$23.08 | 25.49% |
2015 | -$18.39 | -98.31% |
2014 | -$1,085 | -1043.69% |
2013 | $115.02 | -112.27% |
2012 | -$937.43 | 136.36% |
2011 | -$396.60 | -61.4% |
2010 | -$1,028 | -64.81% |
2009 | -$2,920 | -54.24% |
2008 | -$6,382 | -65.73% |
2007 | -$18,622 | 183.35% |
2006 | -$6,572 | 587.86% |
2005 | -$955.46 | -84.55% |
2004 | -$6,183 | 28.95% |
2003 | -$4,795 | -26.11% |
2002 | -$6,490 | 53.19% |
2001 | -$4,236 | -6% |
2000 | -$4,507 | -22.74% |
1999 | -$5,833 |